The COVID‐19 Global Rheumatology Alliance is a global collaboration of rheumatologists, scientists, patients and organisations all committed to addressing the issues in rheumatology created by the COVID‐19 global pandemic. To date the alliance has published important data on the effect of COVID‐19 infection on outcomes and the effect of rheumatic medications on COVID‐19 outcomes.
We currently have 3520 cases from all over the world but we still need to collect many more cases and we need cases from all around the world including the Asia‐Pacific region. We are hoping for more cases from the Asia‐Pacific region because this is currently under‐represented in the registry.
To contribute we ask that you provide details of the case, rheumatic diagnosis details, treatments, and the outcome of the case.
You can join the mailing list for the COVID‐19 Global Rheumatology Alliance by signing up on our webpage (top right hand corner)
For more information please visit our website at www.rheum‐covid.org, if you have questions or issues and would like to know more information please email rheum.covid@gmail.com.
Your help is needed in the fight against COVID‐19: Please contribute to the COVID‐19 Global Rheumatology Alliance Registry. Int J Rheum Dis. 2020;23:1606–1606. 10.1111/1756-185X.14026